The role of paraoxonase (PON1) in the detoxication of organophosphates and its human polymorphism

Chemico-Biological Interactions

Volumn 119-120, Issue , 1999, Pages 429-438

  Costa, L G ^a   Li, W F ^a   Richter, R J ^a   Shih, D M ^b   Lusis, A ^b   Furlong, C E ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Chlorpyrifos; Diazinon; Paraoxonase; Parathion; PON1; Sarin; Soman

Indexed keywords

ACETYLCHOLINESTERASE; ARYLDIALKYLPHOSPHATASE; CHLORPYRIFOS; DIAZOXON; DIMPYLATE; DISULFOTON; INSECTICIDE; ORGANOPHOSPHATE; PARAOXON; PARATHION METHYL; PHENYLACETIC ACID; SARIN; SOMAN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; CONFERENCE PAPER; DETOXIFICATION; ENZYME ACTIVITY; ENZYME POLYMORPHISM; GENETIC VARIABILITY; HUMAN; HYDROLYSIS; KNOCKOUT MOUSE; MOUSE; NONHUMAN; POLYMERASE CHAIN REACTION;

ANIMALS; ARYLDIALKYLPHOSPHATASE; ESTERASES; HUMANS; METABOLIC DETOXICATION, DRUG; MICE; MICE, KNOCKOUT; PHOSPHORIC ACID ESTERS; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC;

ANIMALIA; ORYCTOLAGUS CUNICULUS; RODENTIA;

EID: 0033064345     PISSN: 00092797     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0009-2797(99)00055-1     Document Type: Conference Paper

References (48)

1. Aldridge W.N. Serum esterases II. An enzyme hydrolyzing p-nitrophenyl phosphate (E600) and its identity with the A-esterase of mammalian sera. Biochem. J. 53:1953;117-124.
2. Furlong C.E., Costa L.G., Hassett C., Richter R.J., Adler D.A., Disteche C.M., Omiecinski C.J., Chapline C., Crabb J.W., Humbert R. Human and rabbit paraoxonases: purification, cloning, sequencing, mapping and role of polymorphism in organophosphate detoxification. Chem.-Biol. Interact. 87:1993;35-48.
3. Sorenson R.C., Primo-Parmo S.L., Kuo C.-L., Adkins S., Lockridge O., La Du B.N. Reconsideration of the catalytic center and mechanism of mammalian paraoxonase;arylesterase. Proc. Natl. Acad. Sci. USA. 92:1995;7187-7191.
4. La Du B.N., Piko J.I., Eckerson H.W., Vincent-Viry M., Seist G. An improved method for phenotyping individuals for the human serum paraoxonase arylesterase polymorphism. Ann. Biol. Clin. 44:1986;369-372.
5. Krisch K. Enzymatische hydrolyse von diathyl-p-nitrophenylphosphat (E600) durch menschliches serum. Z. Klin. Chem. Biochem. 6:1968;41.
6. Geldmacher-v. Mallinckrodt M., Lindorf H.H., Petenyi M., Flügel M., Fischer T., Hiller T. Genetisch determinierter polymorphismus der menschlichen serum-paraoxonase (EC 3.1.1.3). Humangenetik. 17:1973;331-335.
7. Playfer J.R., Eze L.C., Bullen M.F., Evans D.A.P. Genetic polymorphism and interethnic variability of plasma paraoxonase activity. J. Med. Genet. 13:1976;337-342.
8. Ortigoza-Ferado J., Richter R.J., Hornung S., Motulsky A.G., Furlong C.E. Paraoxon hydrolysis in human serum mediated by a genetically variable arylesterase and albumin. Am. J. Hum. Genet. 36:1984;295-305.
9. Furlong C.E., Richter R.J., Chapline C., Crabb J.W. Purification of rabbit and human serum paraoxonase. Biochemistry. 30:1991;10133-10140.
10. Gan K.N., Smolen A., Eckerson H.W., La Du B.N. Purification of human serum paraoxonase/arylesterase. Evidence for one esterase catalyzing both activities. Drug. Metab. Dispos. 19:1991;100-106.
11. Hassett C., Richter R.J., Humbert R., Chapline C., Crabb J.W., Omiecinski C.J., Furlong C.E. Characterization of cDNA clones encoding rabbit and human serum paraoxonase: the mature protein retains its signal sequence. Biochemistry. 30:1991;10141-10149.
12. Humbert R., Adler D.A., Disteche C.M., Hassett C., Omiecinski C.J., Furlong C.E. The molecular basis of the human serum paraoxonase activity polymorphism. Nat. Genet. 3:1993;73-76.
13. Adkins S., Gan K.N., Mody M., La Du B.N. Molecular basis for the polymorphic forms of human serum paraoxonase/arylesterase: glutamine or arginge at position 191 for the respective A or B allozymes. Am. J. Hum. Genet. 52:1993;598-608.
14. Shih D.M., Gu L., Hama S., Xia Y.-R., Navab M., Fogelman A.M., Lusis A.J. Genetic-dietary regulation of serum paraoxonase expression and its role in atherogenesis in a mouse model. J. Clin. Invest. 97:1996;1630-1639.
15. Li W.-F., Matthews C., Disteche C.M., Costa L.G., Furlong C.E. Paraoxonase (PON1) gene in mice: sequencing, chromosomal localization and developmental expression. Pharmacogenetics. 7:1997;137-144.
16. Primo-Parmo S.L., Sorenson R.C., Teiber J., La Du B.N. The human serum paraoxonase/arylesterase gene (PON1) is one member of a multigene family. Genomics. 33:1996;498-507.
17. Geldmacher-v. Mallinckrodt M., Diepgen T.L. The human serum paraoxonase-polymorphism and specificity. Toxicol. Environ. Chem. 18:1988;79-196.
18. Walker C.H., Mackness M.I. A-esterases and their role in regulating the toxicity of organophosphates. Arch. Toxicol. 60:1987;30-33.
19. Pellin M.C., Moretto A., Lotti M., Vilanova E. Distribution and some biochemical properties of rat paraoxonase activity. Neurotoxicol. Teratol. 12:1990;611-614.
20. Main A.R. The role of A-esterase in the acute toxicity of paraoxon, TEPP and parathion. Can. J. Biochem. Physiol. 34:1956;197-216.
21. Machin A.F., Anderson P.H., Quick M.P., Waddell D.F., Skibniewska K.A., Howells L.C. The metabolism of diazinon in the liver and blood of species of varying susceptibility to diazinon poisoning. Xenobiotica. 6:1976;104.
22. Brealey C.J., Walker C.H., Baldwin B.C. A-esterase activities in relation to the differential toxicity of pirimiphos-methyl to birds and mammals. Pest. Sci. 11:1980;546-554.
23. Costa L.G., Richter R.J., Murphy S.D., Omenn G.S., Motulsky A.G., Furlong C.E. Species differences in serum paraoxonase correlate with sensitivity to paraoxon toxicity. Costa L.G., Galli C.L., Murphy S.D. Toxicology of Pesticides: Experimental Clinical and Regulatory Perspectives. 1987;93-107 Springer, Heidelberg.
24. Costa L.G., McDonald B.E., Murphy S.D., Omenn G.S., Richter R.J., Motulsky A.G., Furlong C.E. Serum paraoxonase and its influence on paraoxon and chlorpyrifos oxon toxicity in rats. Toxicol. Appl. Pharmacol. 103:1990;66-76.
25. Li W.-F., Costa L.G., Furlong C.E. Serum paraoxonase status: a major factor in determining resistance to organophosphates. J. Toxicol. Environ. Health. 40:1993;337-346.
26. Li W.-F., Furlong C.E., Costa L.G. Paraoxonase protects against chlorpyrifos toxicity in mice. Toxicol. Lett. 76:1995;219-226.
27. Shih D.M., Gu L., Xia Y.R., Navab M., Li W.F., Hama S., Castellani L.W., Furlong C.E., Costa L.G., Fogelman A.M., Lusis A.J. Mice lacking serum paraoxonase are susceptible to organophosphate toxicity and atherosclerosis. Nature. 394:1998;284-287.
28. Brodeur J., Du Bois K.P. Comparison of acute toxicity of anticholinesterase insecticides to weanling and adult male rats. Proc. Soc. Exp. Biol. Med. 114:1963;509-511.
29. Lu F.C., Jessup D.C., Lavallee A. Toxicity of pesticides in young versus adult rats. Food Cosmet. Toxicol. 3:1965;591-596.
30. Benke G.M., Murphy S.D. The influence of age on the toxicity and metabolism of methyl parathion and parathion in male and female rats. Toxicol. Appl. Pharmacol. 31:1975;254-269.
31. Harbison R.D. Comparative toxicity of some selected pesticides in neonatal and adult rats. Toxicol. Appl. Pharmacol. 32:1975;443-446.
32. Pope C.N., Chakraborti T.K., Chapman M.L., Farrar J.D., Arthun D. Comparison of the in vivo cholinesterase inhibition in neonatal and adult rats by three organophosphorothioate insecticides. Toxicology. 68:1991;51-61.
33. Pope C.N., Chakraborti T.K. Dose-related inhibition of brain and plasma cholinesterase in neonatal and adult rats following sublethal organophosphate exposure. Toxicology. 73:1992;35-43.
34. Mortensen S.R., Hooper M.J., Padilla S. Age-related sensitivity to cholinesterase inhibiting pesticides: is the brain acetylcholinesterase from young animals intrinsically more sensitive to inhibition? Toxicologist. 15:1995;206.
35. Gagné J., Brodeur J. Metabolic studies on the mechanisms of increased susceptibility of weanling rats to parathion. Can. J. Physiol. Pharmacol. 50:1972;902-915.
36. Murphy S.D. Toxicity and hepatic metabolism of organophosphate insecticides in developing rats. Banbury Rep. 11:1982;125-136.
37. Mortensen S.R., Chanda S.M., Hooper M.J., Padilla S. Maturational differences in chlorpyrifos-oxonase activity may contribute to age-related sensitivity to chlorpyrifos. J. Biochem. Toxicol. 11:1996;279-287.
38. Virgo B.B. Pesticides and the neonate. Kacew S., Reasor M.J. Toxicology and the Newborn. 1984;252-267 Elsevier, Amsterdam.
39. Augustinsson K.B., Barr M. Age variation in plasma arylesterase activity in children. Clin. Chem. Acta. 8:1963;568-573.
40. Mueller R.F., Hornung S., Furlong C.E., Anderson J., Giblett E.R., Motulsky A.G. Plasma paraoxonase polymorphism: a new enzyme assay, population, family, biochemical and linkage studies. Am. J. Hum. Genet. 35:1983;393-408.
41. Weitman S.D., Vodicnik M.J., Lech J.J. Influence of pregnancy on parathion toxicity and disposition. Toxicol. Appl. Pharmacol. 71:1983;215-224.
42. Davies H., Richter R.J., Keifer M., Broomfield C., Sowalla J., Furlong C.E. The effect of the human serum paraoxonase polymorphism is reversed with diazoxon, soman and sarin. Nat. Genet. 14:1996;334-336.
43. Odawara M., Tachi Y., Yamashita K. Paraoxonase polymorphism (Gln192-Arg) is associated with coronary heart disease in Japanese non-insulin dependent diabetes mellitus. J. Clin. Endocrinol. Metabol. 82:1997;2257-2260.
44. Zama T., Murata M., Matsubara Y., Kawano K., Aoki N., Yoshino H., Watanabe G., Ishikawa K., Ikeda Y. A 192 Arg variant of the human paraoxonase (HUMPONA) gene polymorphism is associated with an increased risk for coronary artery disease in the Japanese. Arterioscler. Thromb. Vasc. Biol. 17:1997;3565-3569.
45. Suehiro T., Nakauchi Y., Yamamoto M., Arii K., Itoh H., Hamashige N., Hashimoto K. Paraoxonase gene polymorphism in Japanese subjects with coronary heart disease. Int. J. Cardiol. 57:1996;69-73.
46. Antikainen M., Murtomaki S., Syvanne M., Pahlman R., Tahvanainen E., Jauhiainen M., Frick M.H., Ehnholm C. The Gln-Arg191 polymorphism of the human paraoxonase gene (HUMPONA) is not associated with the risk of coronary artery disease in Finns. J. Clin. Invest. 98:1996;883-885.
47. Ruiz J., Blanché H., James R.W. Gln-Arg192 polymorphism of paraoxonase and coronary heart disease in type 2 diabetes. Lancet. 346:1995;869-872.
48. Serrato M., Jarian A.J. A variant of human paraoxonase arylesterase (HUMPONA) gene is a risk factor for coronary artery disease. J. Clin. Invest. 96:1996;3005-3008.